{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:14:15Z","timestamp":1789456455997,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"DOI":"10.7759\/cureus.116254","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:59:56Z","timestamp":1789455596000},"source":"Crossref","is-referenced-by-count":0,"title":["Medication Adherence in Patients With Glaucoma and Determinants of Treatment Adherence: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Sujata R","family":"Charel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishva S","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuti S","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaini","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053805","article-title":"Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017","volume":"12","author":"Sun Y","year":"2022","unstructured":"Sun Y, Chen A, Zou M, et al.. Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017. BMJ Open. 2022, 12:e053805. 10.1136\/bmjopen-2021-053805","journal-title":"BMJ Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0225","article-title":"The diagnosis and treatment of glaucoma","volume":"117","author":"Schuster AK","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020, 117:225-34. 10.3238\/arztebl.2020.0225","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s10441","article-title":"Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension","volume":"4","author":"Lee AJ","year":"2010","unstructured":"Lee AJ, McCluskey P. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol. 2010, 4:741-64. 10.2147\/opth.s10441","journal-title":"Clin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study","volume":"127","author":"Newman-Casey PA","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2020, 127:477-83. 10.1016\/j.ophtha.2019.10.022","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2025.10.003","article-title":"The effect of medication adherence on intraocular pressure and glaucoma progression","volume":"9","author":"Almidani L","year":"2026","unstructured":"Almidani L, Pan A, Bradley C, Pham A, Yohannan J. The effect of medication adherence on intraocular pressure and glaucoma progression. Ophthalmol Glaucoma. 2026, 9:158-65. 10.1016\/j.ogla.2025.10.003","journal-title":"Ophthalmol Glaucoma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31821dac86","article-title":"Determinants of medication adherence to topical glaucoma therapy","volume":"21","author":"Dreer LE","year":"2012","unstructured":"Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma. 2012, 21:234-40. 10.1097\/IJG.0b013e31821dac86","journal-title":"J Glaucoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17469899.2019.1635456","article-title":"Medication adherence in patients with ocular hypertension or glaucoma","volume":"14","author":"Robin AL","year":"2019","unstructured":"Robin AL, Muir KW. Medication adherence in patients with ocular hypertension or glaucoma. Expert Rev Ophthalmol. 2019, 14:199-210. 10.1080\/17469899.2019.1635456","journal-title":"Expert Rev Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_806_23","article-title":"Factors affecting adherence to glaucoma medication: patient perspective from North India","volume":"72","author":"Singh K","year":"2024","unstructured":"Singh K, Singh A, Jain D, Verma V. Factors affecting adherence to glaucoma medication: patient perspective from North India. Indian J Ophthalmol. 2024, 72:391-6. 10.4103\/IJO.IJO_806_23","journal-title":"Indian J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijceo.2023.032","article-title":"Study of adherence to topical anti-glaucoma therapy in rural India with exploration of adherence barriers","volume":"9","author":"Bhat AH","year":"2023","unstructured":"Bhat AH, Khateeb EW. Study of adherence to topical anti-glaucoma therapy in rural India with exploration of adherence barriers. Indian J Clin Exp Ophthalmol. 2023, 9:161-7. 10.18231\/j.ijceo.2023.032","journal-title":"Indian J Clin Exp Ophthalmol"},{"key":"ref10","article-title":"Psychometrics of a new questionnaire to assess glaucoma adherence: the Glaucoma Treatment Compliance Assessment Tool (an American Ophthalmological Society thesis)","volume":"111","author":"Mansberger SL","year":"2013","unstructured":"Mansberger SL, Sheppler CR, McClure TM, Vanalstine CL, Swanson IL, Stoumbos Z, Lambert WE. Psychometrics of a new questionnaire to assess glaucoma adherence: the Glaucoma Treatment Compliance Assessment Tool (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013, 111:1-16.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.08.002","article-title":"Adherence and persistence with glaucoma therapy","volume":"53","author":"Schwartz GF","year":"2008","unstructured":"Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008, 53:S57-68. 10.1016\/j.survophthal.2008.08.002","journal-title":"Surv Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-308505","article-title":"Treatment patterns and medication adherence of patients with glaucoma in South Korea","volume":"101","author":"Kim CY","year":"2017","unstructured":"Kim CY, Park KH, Ahn J, et al.. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017, 101:801-7. 10.1136\/bjophthalmol-2016-308505","journal-title":"Br J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2017.09.002","article-title":"Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India","volume":"30","author":"Rajurkar K","year":"2018","unstructured":"Rajurkar K, Dubey S, Gupta PP, John D, Chauhan L. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018, 30:125-9. 10.1016\/j.joco.2017.09.002","journal-title":"J Curr Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2019.01.006","article-title":"Factors affecting adherence to topical glaucoma therapy: a quantitative and qualitative pilot study analysis in Sydney, Australia","volume":"2","author":"Spencer SK","year":"2019","unstructured":"Spencer SK, Shulruf B, McPherson ZE, et al.. Factors affecting adherence to topical glaucoma therapy: a quantitative and qualitative pilot study analysis in Sydney, Australia. Ophthalmol Glaucoma. 2019, 2:86-93. 10.1016\/j.ogla.2019.01.006","journal-title":"Ophthalmol Glaucoma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.985893","article-title":"Treatment adherence and associated factors among glaucoma patients attending ophthalmic units of referral hospitals in North West Ethiopia, 2019","volume":"2","author":"Birhanie SA","year":"2022","unstructured":"Birhanie SA, Getie GA, Tesfa M, et al.. Treatment adherence and associated factors among glaucoma patients attending ophthalmic units of referral hospitals in North West Ethiopia, 2019. Front Ophthalmol (Lausanne). 2022, 2:985893. 10.3389\/fopht.2022.985893","journal-title":"Front Ophthalmol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/521135-medication-adherence-in-patients-with-glaucoma-and-determinants-of-treatment-adherence-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:59:57Z","timestamp":1789455597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/521135-medication-adherence-in-patients-with-glaucoma-and-determinants-of-treatment-adherence-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116254","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}